Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenocarcinoma (Phase 2)
Angiogenesis Inhibitors (Phase 2)
Angiogenesis Modulating Agents (Phase 2)
Antineoplastic Agents, Immunological (Phase 2)
Bile Duct Neoplasms (Phase 2)
Biliary Tract Neoplasms (Phase 2/Phase 3)
Breast Neoplasms (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Neuroendocrine (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Cholangiocarcinoma (Phase 2)
Colorectal Neoplasms (Phase 2)
Drugs, Investigational (Phase 2)
Exocrine Pancreatic Insufficiency (Phase 1)
Fallopian Tube Neoplasms (Phase 1/Phase 2)
Gallbladder Neoplasms (Phase 2)
Hamartoma (Phase 2)
Healthy Volunteers (Phase 1)
Immunotherapy (Phase 2)
Intestinal Neoplasms (Phase 2)
Kidney Failure, Chronic (Phase 1)
Liver Diseases (Phase 1)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 1/Phase 2)
Nasopharyngeal Carcinoma (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neuroendocrine Tumors (Phase 3)
Osteosarcoma (Phase 1/Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Rhabdomyosarcoma (Phase 1/Phase 2)
Sarcoma (Phase 2)
Sarcoma, Ewing (Phase 1/Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 2)
Thyroid Carcinoma, Anaplastic (Phase 1/Phase 2)
Thyroid Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue